Literature DB >> 32100243

miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.

Qing Liu1,2, Zhenting Wang1,3, Xiaohua Zhou2, Mingying Tang2, Wei Tan1,2, Tianshi Sun2, Yifang Wang2, Youwen Deng4.   

Abstract

Osteosarcoma (OS) is closely related to the dysregulation of various intracellular signaling pathways, especially the PI3K/Akt signaling pathway. Reportedly, HSP90 was responsible for phospho-Akt stabilization, and both AKT1 and HSP90 were upregulated within osteosarcoma. Herein, we demonstrated that AKT1 and HSP90 mRNA and protein expression were upregulated within osteosarcoma tissues and cells; AKT1 knockdown significantly inhibited OS cell viability. HSP90 knockdown suppressed the phosphorylation of AKT1, decreased ki-67 and Vimentin protein levels, enhanced p21 and E-cadherin protein levels, and inhibited OS cell proliferation and migration; AKT1 overexpression exerted opposing effects and significantly attenuated the effects of HSP90 knockdown. miR-485-5p targeted AKT1 and HSP90 3'-UTR to inhibit AKT1 and HSP90 expression. miR-485-5p overexpression dramatically reduced AKT1, HSP90, and ki-67 proteins, increased E-cadherin protein levels, and inhibited OS cell proliferation and migration. In conclusion, HSP90 knockdown blocked the phosphorylation of AKT1 suppressing the proliferation and migration capacity of OS cells via the PI3K/AKT pathway; miR-485-5p binds to HSP90 and AKT1 in their 3'-UTR to inhibit HSP90 and AKT1 expression, therefore exerting a tumor suppressor function within osteosarcoma.

Entities:  

Keywords:  AKT1; HSP90; Osteosarcoma (OS); PI3K/AKT signaling pathway; miR-485-5p

Mesh:

Substances:

Year:  2020        PMID: 32100243     DOI: 10.1007/s13105-020-00730-8

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  10 in total

1.  MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.

Authors:  Yupeng Chen; Lin Wu; Min Bao
Journal:  Mol Biotechnol       Date:  2022-10-11       Impact factor: 2.860

2.  Differential expression profile of plasma exosomal microRNAs in acute type A aortic dissection with acute lung injury.

Authors:  Chiyuan Zhang; Hui Bai; Lei Zhang; Yanfeng Zhang; Xuliang Chen; Ruizheng Shi; Guogang Zhang; Qian Xu; Guoqiang Lin
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

3.  Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma.

Authors:  Ting Chen; Jinxin Liu; He Zhang; Jiatong Li; Guanning Shang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

4.  Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis.

Authors:  Qing Liu; Hao Zeng; Yuhao Yuan; Zhiwei Wang; Ziyi Wu; Wei Luo
Journal:  Genes Dis       Date:  2020-06-27

5.  Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.

Authors:  Jie Zeng; Si-Li He; Li-Jie Li; Chen Wang
Journal:  Mol Med       Date:  2021-10-19       Impact factor: 6.354

6.  Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p.

Authors:  Yongheng Liu; Guanghao Li; Yan Zhang; Lili Li; Yanting Zhang; Xiaoyu Huang; Xianfu Wei; Peng Zhou; Ming Liu; Gang Zhao; Jinyan Feng; Guowen Wang
Journal:  Cancer Cell Int       Date:  2022-08-11       Impact factor: 6.429

7.  HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.

Authors:  Hongbo Zhang; Xiteng Yin; Xinyu Zhang; Meng Zhou; Wenguang Xu; Zheng Wei; Chuanhui Song; Shengwei Han; Wei Han
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

8.  The Chaperone System in Salivary Glands: Hsp90 Prospects for Differential Diagnosis and Treatment of Malignant Tumors.

Authors:  Charbel A Basset; Francesca Rappa; Rosario Barone; Ada Maria Florena; Rossana Porcasi; Everly Conway de Macario; Alberto J L Macario; Angelo Leone
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

9.  Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway.

Authors:  Xinbo Wu; Haiyang Yu; Haichao Zhou; Zihua Li; Hui Huang; Fajiao Xiao; Shaochen Xu; Yunfeng Yang
Journal:  J Cell Mol Med       Date:  2020-09-10       Impact factor: 5.310

Review 10.  Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.

Authors:  Morgane Lallier; Louise Marchandet; Brice Moukengue; Celine Charrier; Marc Baud'huin; Franck Verrecchia; Benjamin Ory; François Lamoureux
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.